Literature DB >> 14245769

CRYSTALLINE HUMAN UROKINASE: SOME PROPERTIES.

A LESUK, L TERMINIELLO, J H TRAVER.   

Abstract

Human urokinase, an enzyme which activates plasminogen, has been crystallized. Repeated recrystallization yielded preparations of maximum specific activity; such preparations revealed only one component when subjected to polyacrylamide gel disc electrophoresis. Studies with the ultracentrifuge demonstrated that urokinase undergoes a concentration-dependent reversible association at pH 6.8. When the partial specific volume of the enzyme is assumed to be 0.735 milliliters per gram at 10 degrees C, Archibald measurements indicate the molecular weight of urokinase to be 53,000.

Entities:  

Keywords:  CRYSTALLIZATION; CRYSTALLOGRAPHY; ELECTROPHORESIS; EXPERIMENTAL LAB STUDY; MOLECULAR WEIGHT; STREPTODORNASE AND STREPTOKINASE; ULTRACENTRIFUGATION

Mesh:

Substances:

Year:  1965        PMID: 14245769     DOI: 10.1126/science.147.3660.880

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  10 in total

Review 1.  Anticoagulant and thrombolytic drugs. I. Patho-physiological and pharmacological aspects.

Authors:  D Ogston; A S Douglas
Journal:  Drugs       Date:  1971       Impact factor: 9.546

2.  Oral contraceptives and urokinase activity.

Authors:  H A Moses; R E Hardy; H M Frazier
Journal:  J Natl Med Assoc       Date:  1969-11       Impact factor: 1.798

3.  Effective and fibrin-specific clot lysis by a zymogen precursor form of urokinase (pro-urokinase). A study in vitro and in two animal species.

Authors:  V Gurewich; R Pannell; S Louie; P Kelley; R L Suddith; R Greenlee
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

4.  Some characteristics of urokinase released in organ culture of human kidney.

Authors:  B Astedt; B Bladh; L Holmberg
Journal:  Experientia       Date:  1977-05-15

5.  Expression in Escherichia coli of biologically active enzyme by a DNA sequence coding for the human plasminogen activator urokinase.

Authors:  B Ratzkin; S G Lee; W J Schrenk; R Roychoudhury; M Chen; T A Hamilton; P P Hung
Journal:  Proc Natl Acad Sci U S A       Date:  1981-06       Impact factor: 11.205

Review 6.  Antithrombotic drugs: part II.

Authors:  A S Gallus; J Hirsh
Journal:  Drugs       Date:  1976       Impact factor: 9.546

7.  Effect of urokinase antiserum on plasminogen activators: demonstration of immunologic dissimilarity between plasma plasminogen activator and urokinase.

Authors:  C S Kucinski; A P Fletcher; S Sherry
Journal:  J Clin Invest       Date:  1968-06       Impact factor: 14.808

8.  Partial purification and properties of a plasminogen activator from human erythrocytes.

Authors:  M Semar; L Skoza; A J Johnson
Journal:  J Clin Invest       Date:  1969-10       Impact factor: 14.808

9.  Purification of rabbit kidney cytokinase and a comparison of its properties with human urokinase.

Authors:  S Y Ali; L Evans
Journal:  Biochem J       Date:  1968-03       Impact factor: 3.857

10.  Urinary plasminogen activator activity in progressive renal failure.

Authors:  S Y Hong; D H Yang
Journal:  Korean J Intern Med       Date:  1990-01       Impact factor: 2.884

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.